CelLBxHealth PLC (CLBX)

Industry Diagnostics & Research
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

1.30p

Buy

1.35p

arrow-up0.00p (+0.00%)

Prices updated at 05 Aug 2026, 15:11 BST
| Prices minimum 15 mins delay
|
Prices in GBX
CelLBxHealth PLC is engaged in the development and commercialisation of the Parsortix platform, with deployment in liquid biopsy - non-invasive cancer diagnostics. It operates in single segment of commercialisation of its Parsortix cell separation pla ...
FTSE All-Share
arrow-up0.15%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
our Investment Fees and Charges.
Sector
Healthcare
Industry
Diagnostics & Research
Chairman
Dr. Jan Groen
CEO
-
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
114
Head office
10 Nugent Road
Guildford
United Kingdom
GU2 7AF
mobile
+44 1483343434
letter
investor@angleplc.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Dr. Jan Groen
Executive Director, Chairman
-

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
Unicorn Asset Management Ltd2,769,230
Unicorn AIM VCT Series 3 ORD2,769,230
Maven Capital Partners UK LLP133,333
Zeus Investment Management Limited-
Jackson National-

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
15 Dec 2025Purchase
15 Dec 2025Purchase
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser.

© Copyright 2026 Morningstar. All rights reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

The ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.